Literature DB >> 18520679

Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women.

Janneke H H M van de Wijgert1, Charles S Morrison, Peter G A Cornelisse, Marshall Munjoma, Jeanne Moncada, Peter Awio, Jing Wang, Barbara Van der Pol, Tsungai Chipato, Robert A Salata, Nancy S Padian.   

Abstract

OBJECTIVE: To evaluate interrelationships between bacterial vaginosis (BV), vaginal yeast, vaginal practices (cleansing and drying/tightening), mucosal inflammation, and HIV acquisition.
METHODS: A multicenter, prospective, observational cohort study was conducted, enrolling 4531 HIV-negative women aged 18 to 35 years attending family planning clinics in Zimbabwe and Uganda. Participants were tested for HIV and reproductive tract infections and were interviewed about vaginal practices every 3 months for 15 to 24 months. BV was measured by Gram stain Nugent scoring, vaginal yeast by wet mount, and mucosal inflammation by white blood cells on Gram stain.
RESULTS: HIV incidence was 4.12 and 1.53 per 100 woman-years of follow-up in Zimbabwe and Uganda, respectively (a total of 213 incident infections). Women with BV or vaginal yeast were more likely to acquire HIV, especially if the condition was present at the same visit as the new HIV infection and the visit preceding it (hazard ratio [HR] = 2.50, 95% confidence interval [CI]: 1.68 to 3.72 and HR = 2.97, 95% CI: 1.67 to 5.28 for BV and yeast, respectively). These relationships did not seem to be mediated by mucosal inflammation. Vaginal drying/tightening was associated with HIV acquisition in univariate (HR = 1.49, 95% CI: 1.03 to 2.15) but not multivariate models. Vaginal cleansing was not associated with HIV acquisition.
CONCLUSIONS: BV and yeast may contribute more to the HIV epidemic than previously thought.

Entities:  

Mesh:

Year:  2008        PMID: 18520679     DOI: 10.1097/QAI.0b013e3181743936

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  63 in total

1.  Expanded safety and acceptability of the candidate vaginal microbicide Carraguard® in South Africa.

Authors: 
Journal:  Contraception       Date:  2010-05-26       Impact factor: 3.375

2.  Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization.

Authors:  Barb Lohman-Payne; Jennifer Slyker; Sarah L Rowland-Jones
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

3.  Vaginal practices, microbicides and HIV: what do we need to know?

Authors:  A Martin Hilber; M F Chersich; J H H M van de Wijgert; H Rees; M Temmerman
Journal:  Sex Transm Infect       Date:  2007-12       Impact factor: 3.519

4.  Changes in Vaginal Microbiota and Immune Mediators in HIV-1-Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate.

Authors:  Alison C Roxby; David N Fredricks; Katherine Odem-Davis; Kristjana Ásbjörnsdóttir; Linnet Masese; Tina L Fiedler; Stephen De Rosa; Walter Jaoko; James N Kiarie; Julie Overbaugh; R Scott McClelland
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-01       Impact factor: 3.731

5.  Establishing and sustaining a healthy vaginal environment: analysis of data from a randomized trial of periodic presumptive treatment for vaginal infections.

Authors:  Jennifer E Balkus; Barbra A Richardson; Kishorchandra Mandaliya; James Kiarie; Walter Jaoko; Jeckoniah O Ndinya-Achola; Jeanne Marrazzo; Carey Farquhar; R Scott McClelland
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226

6.  An effective intervention to reduce intravaginal practices among HIV-1 uninfected Kenyan women.

Authors:  Sumathi Sivapalasingam; R Scott McClelland; Jacques Ravel; Aabid Ahmed; Charles M Cleland; Pawel Gajer; Musa Mwamzaka; Fatma Marshed; Juma Shafi; Linnet Masese; Mark Fajans; Molly E Anderson; Walter Jaoko; Ann E Kurth
Journal:  AIDS Res Hum Retroviruses       Date:  2014-09-29       Impact factor: 2.205

7.  Vaginal practices and associations with barrier methods and gel use among Sub-Saharan African women enrolled in an HIV prevention trial.

Authors:  Ariane van der Straten; Helen Cheng; Agnes Chidanyika; Guy De Bruyn; Nancy Padian
Journal:  AIDS Behav       Date:  2010-06

8.  Prevalence of sexually transmitted infections among pregnant women with known HIV status in northern Tanzania.

Authors:  Sia E Msuya; Jacqueline Uriyo; Akhtar Hussain; Elizabeth M Mbizvo; Stig Jeansson; Noel E Sam; Babill Stray-Pedersen
Journal:  Reprod Health       Date:  2009-02-25       Impact factor: 3.223

Review 9.  Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis.

Authors:  Adriane Martin Hilber; Suzanna C Francis; Matthew Chersich; Pippa Scott; Shelagh Redmond; Nicole Bender; Paolo Miotti; Marleen Temmerman; Nicola Low
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

10.  Bacterial vaginosis in female facility workers in north-western Tanzania: prevalence and risk factors.

Authors:  K Baisley; J Changalucha; H A Weiss; K Mugeye; D Everett; I Hambleton; P Hay; D Ross; C Tanton; T Chirwa; R Hayes; D Watson-Jones
Journal:  Sex Transm Infect       Date:  2009-05-26       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.